Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 8, 2005, Pages 844-850

  Chinushi, Masaomi ^a   Sugiura, Hirotaka ^a   Komura, Satoru ^a   Hirono, Takashi ^a   Izumi, Daisuke ^a   Tagawa, Minoru ^a   Furishima, Hiroshi ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Magnesium therapy; Polymorphic ventricular tachycardia; Prolonged QT interval; Repolarization dispersion

Indexed keywords

ANTHOPLEURIN A; MAGNESIUM SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROGRAPHY; HEART LEFT VENTRICLE WALL; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; NONHUMAN; QT PROLONGATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; ELECTROCARDIOGRAPHY; INJECTIONS, INTRAVENOUS; LONG QT SYNDROME; MAGNESIUM SULFATE; TACHYCARDIA, VENTRICULAR;

EID: 27844518425     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00178.x     Document Type: Article

References (28)

1. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottliet S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392-397.
2. Kurita T, Ohe T, Shimizu W, Hotta D, Shimomura K. Early after-depolarization in a patient with complete atrioventricular block and torsades de pointes. Pacing Clin Electrophysiol 1993; 16:33-38.
3. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994; 23:259-277.
4. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological mechanism of ventricular tachyarrhythmias in the long QT syndrome: Three-dimensional mapping of activation and recovery patterns. Circ Res 1996; 79:474-492.
5. Chinushi M, Kozhevnikov D, Caref EB, Restivo M, El-Sherif N. Mechanism of discordant T wave alternans in the in vivo heart. J Cardiovasc Electrophysiol 2003; 14:632-638.
6. Sicouri S, Fish J, Antzelevitch C. Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 1994; 5:824-837.
7. Chinushi M, Kasai H, Tagawa M, Washizuka T, Hosaka Y, Chinushi Y, Aizawa Y. Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes. J Am Coll Cardiol 2002; 40:555-562.
8. Millar CK, Kralios FA, Lux RL. Correlation between refractory periods and ARIs from electrograms: Effects of rate and adrenergic interventions. Circulation 1985; 72:1372-1379.
9. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation recovery intervals from electrograms: Effect of interventions that alter repolarization time. Circulation 1991; 81:281-288.
10. Chinushi M, Hosaka Y, Washizuka T, Furushima H, Aizawa Y, Arrhythmogenesis of T wave alternans associated with surface QRS complex alternans and the role of ventricular prematurity. J Cardiovasc Electrophysiol 2002; 13:599-604.
11. El-Sherif N, Chinushi M, Caref EB, Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long QT syndrome. Circulation 1997; 96:4392-4399.
12. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000; 35:778-786.
13. Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ. Differential response to Na channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 1996; 78:1009-1015.
14. Verduyn SC, Vos MA, van der Zande J, van der Hulst FF, Wellens HJ. Role of interventricular dispersion of repolzriation in acquired torsade-de-pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 1997; 34:453-463.
15. Shimizu W, Antzelevitch C. Cellular and ionic basis for T-Wave alternans under long QT conditions. Circulation 1999; 99:1499-1507.
16. Surawicz B. Electrophysiological substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989; 14:172-184.
17. Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome. Circulation 2001; 103:2851-2853.
18. Restiovo M, Caref EB, Kozhevnikov DO, El-Sherif N. Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 2004; 15:323-331.
19. Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (Ikr and Iks) in canine ventricular epicardial, midmyocardial, and endocardial myocytes: A weaker Iks contributes to the longer action potential of the M cell. Circ Res 1995; 76:351-365.
20. Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation 1998; 98:1921-1927.
21. 2+in rat phaeochromocytoma cells. J Physiol 1993; 466:683-706.
22. Satoh Y, Sugiyama A, Tamura K, Hashimoto K. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Jpn Circ J 2000; 64:445-451.
23. Bailie DS, Inoue H, Kaseda S, Ben David J, Zipes DP. Magnesium suppression of early afterdepolarizations and ventricular arrhythmias induced by cesium in dogs. Circulation 1988; 118:458-466.
24. Kaseda S, Gilmour RF, Zipes DP. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers. Am Heart J 1989; 118:458-466.
25. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ, Andrews ML, Napolitano C, Li Zliang KT, Medina A, MacCluer JW, for The International Long-QT Syndrome Registry Research Group. Influence of genotype on the clinical course of the long QT syndrome. N Engl J Med 1998; 339:960-965.
26. Schwarte PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AAM, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfleld V, Wattanasirichaigoon D, Corbett C, Haverhamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long QT syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89-95.
27. Chinushi M, Tagawa M, Sugiura H, Komura S, Hosaka Y, Washizuka T, Aizawa Y. Ventricular tachyarrhythmias in a canine model of LQT3 (Arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine) Circ J 2003; 67:263-268.
28. Wei SK, Hanlon SU, Haigney MC. Beta-adrenergic stimulation of pig myocytes with decreased cytosolic free magnesium prolongs the action potential and enhances triggered activity. J Cardiovasc Electrophysiol 2002; 13:587-592.